IGFBP3 and ovarian carcinoma: In this study, data obtained from integration of bioinformatics, cellular and molecular biology analyses showed that ULK2 suppresses ovarian cancer cell growth, invasion and migration via a mechanism involving IGFBP3 in the insulin signaling axis and thus associated with improved prognosis of ovarian cancer patients.